News iSpecimen Inc.

Stocks

ISPC

US45032V3069

Software

Market Closed - Nasdaq 23:00:00 30/10/2026 +03			5-day change	1st Jan Change
0.8255 ^USD	+4.19%		+1.04%	-92.07%

09-04	ISpecimen Inc. entered into an asset purchase agreement to acquire certain artificial intelligence software, intellectual property and related assets of Foldlab AI Ltd from Foldlab AI Ltd. for $4.5 million.	CI
09-01	ISpecimen Inc. Announces CEO Changes	CI

All News

Mentions Relevance

10-29	ISpecimen Offers Next-Day Healthy Donor Blood and Launches Development of AI Agent	NE
09-29	ISpecimen Supports Hospital Validation of New Chemistry Analyzer	NE
09-04	ISpecimen Inc. entered into an asset purchase agreement to acquire certain artificial intelligence software, intellectual property and related assets of Foldlab AI Ltd from Foldlab AI Ltd. for $4.5 million.	CI
09-01	ISpecimen Inc. Announces CEO Changes	CI
08-20	ISpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks	NE
08-20	Ispecimen Inc. Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks	CI
08-15	ISpecimen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-07	ISpecimen Closes $5 Million Public Offering of Common Stock, Warrants	MT
08-07	ISpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants	AQ
08-07	E.F. Hutton & Co. Acts as Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen	AQ
08-06	ISpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants	AQ
05-18	ISpecimen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-12	E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement	AQ
05-11	ISpecimen Inc. announced that it has received $2.500004 million in funding	CI
05-09	ISpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement	AQ
05-08	ISpecimen Inc. announced that it expects to receive $2.499999 million in funding	CI
04-27	ISpecimen Announces 1-for-40 Reverse Stock Split	AQ
04-24	ISpecimen Announces 1-for-40 Reverse Stock Split	NE
04-20	MicroCap Movers: ISPC, ADMQ, DOSE, YXT, CSDX, AMLM, MMCP in the News	AQ
04-14	Ispecimen Inc - annual meeting repeatedly adjourned for lack of quorum - SEC filing	RE
04-09	ISpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time	NE
04-02	ISpecimen Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-01	ISpecimen Inc. Auditor Raises 'Going Concern' Doubt	CI
03-16	ISpecimen Achieves Rapid Procurement Milestone for Influenza Research	NE
03-12	ISpecimen Launches AI Agent Revolutionizing Biospecimen Matching	NE